Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
U.S. stocks traded mostly lower, with the Nasdaq Composite dropping over 60 points on Wednesday. Here are some big stocks recording losses in today’s session.
Sebastian Robertson on Twitter: "One student wounded after reports of a shooting inside #Ingraham High School in North Seattle @KING5Seattle https://t.co/Fvyo5ibicL" / Twitter